Efalizumab

Records for this ingredient, by country (identity only).

ATC L04AG02 · 5 markets · 6 records

Efalizumab 5 markets · 6 records Forms
Filters
MarketJP 2GB 1

JP 2 records · 1 shown of 1 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

  • 6 mg/0.05 mLinjectionバビースモ硝子体内注射液120mg/mLバビースモ硝子体内注射用キット120mg/mL

GB 1 records · 1 shown of 1 Source NHSBSA dm+d · Data as of 2026-10-19

  • 125 mg per mL / per unit basis not statedinjectionRaptiva 125mg powder and solvent for solution for injection vials

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.